{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:23:19Z","timestamp":1792588999704,"version":"4.5.0"},"reference-count":0,"publisher":"Cell Physiol Biochem Press GmbH and Co KG","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Physiol Biochem"],"DOI":"10.33594\/000000178","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T12:05:15Z","timestamp":1573733115000},"page":"865-886","source":"Crossref","is-referenced-by-count":207,"title":["Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor \u03b1-Stimulated Human Coronary Arterial Endothelial Cells"],"prefix":"10.33594","volume":"53","member":"19235","published-online":{"date-parts":[[2019,11,16]]},"container-title":["Cellular Physiology and Biochemistry"],"original-title":[],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T12:05:16Z","timestamp":1573733116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cellphysiolbiochem.com\/Articles\/000178\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,16]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,11,16]]}},"URL":"https:\/\/doi.org\/10.33594\/000000178","relation":{},"ISSN":["1015-8987","1421-9778"],"issn-type":[{"value":"1015-8987","type":"print"},{"value":"1421-9778","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,16]]}}}